Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.370
+0.020 (1.48%)
May 26, 2026, 5:23 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 41.65 million as of May 26, 2026. Its market cap has decreased by -46.85% in one year.
Market Cap
41.65M
Enterprise Value
31.58M
Revenue
32.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.37
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 41.65M, a decrease of -83.07%. That is a compound annual growth rate of -33.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 41.04M | 17.39% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 772.20M |
| Orexo AB | 692.15M |
| Nanexa AB | 670.78M |
| Enzymatica AB | 577.71M |
| Cinclus Pharma Holding AB | 562.18M |
| Moberg Pharma AB | 474.71M |
| Dicot Pharma AB | 457.73M |
| Klaria Pharma Holding AB (publ.) | 198.99M |